INSMED INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.11 USD | +118.67% |
|
+96.11% | +55.23% |
| 09:45am | Insmed Plans $500 Million Public Offering | MT |
| 05-28 | Sector Update: Health Care Stocks Fall Late Afternoon | MT |
Presenter SpeechJason Zemansky (Analysts)Thank you for joining us, and this is our first day o...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs, brensocatib and TPIP, as well as other early-stage research programs. Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1), which is developing for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRSsNP). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil, which offers a differentiated product profile for pulmonary hypertension associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH).
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
48.06
USD
Average target price
52.62
USD
Spread / Average Target
+9.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +55.23% | 7.14B | |
| +9.83% | 115B | |
| +10.80% | 105B | |
| -10.84% | 22.71B | |
| -1.19% | 21.83B | |
| -10.93% | 18.18B | |
| -41.92% | 16.52B | |
| -15.11% | 16.01B | |
| +6.62% | 14.14B | |
| +17.53% | 10.71B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- Transcript : Insmed Incorporated Presents at Bank of America Health Care Conference 2024, May-14-2024 02
